FdaApplication
ANDA 216966
Identifiers
- fda_app_no: ANDA216966
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-06-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANGIOTENSIN LL ACETATE | ANGIOTENSIN II ACETATE | EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) | SOLUTION;INTRAVENOUS |
1 product